Table 4.

Factors associated with progression to PSCR and no SCR at end of follow-up

Progression to PSCR (analysis on n = 109)No SCR at end of follow-up (analysis on n = 126)
Unadjusted OR (95% CI)P valueUnadjusted OR (95% CI)P value 
Gender     
Male Reference  Reference  
Female 0.404 (0.126-1.297) .128 2.485 (1.210-5.101) .013 
Hb genotype     
HbSS/HbSβ0/HbSβ+ Reference  3.726 (1.699-8.169)  
HbSC 5.973 (1.812-19.684) .003 Reference .001 
Age     
0.988 (95% CI, 0.934-1.045) .671 0.977 (95% CI, 0.946-1.009) .161 
HbF     
0.812 (0.663-0.993) .043 1.201 (1.093-1.319) .001 
Hb level     
mmol/L 1.565 (0.883-2.774) .125 0.673 (0.479-0.946) .022 
Lactate dehydrogenase     
U/L 0.997 (0.993-1.000) .086 1.001 (0.999-1.003) .232 
Bilirubin     
μmol/L 1.001 (0.987-1.016) .856 1.003 (0.993-1.013) .601 
Reticulocytes     
0.996 (0.882-1.124) .944 1.019 (0.943-1.100) .640 
Progression to PSCR (analysis on n = 109)No SCR at end of follow-up (analysis on n = 126)
Unadjusted OR (95% CI)P valueUnadjusted OR (95% CI)P value 
Gender     
Male Reference  Reference  
Female 0.404 (0.126-1.297) .128 2.485 (1.210-5.101) .013 
Hb genotype     
HbSS/HbSβ0/HbSβ+ Reference  3.726 (1.699-8.169)  
HbSC 5.973 (1.812-19.684) .003 Reference .001 
Age     
0.988 (95% CI, 0.934-1.045) .671 0.977 (95% CI, 0.946-1.009) .161 
HbF     
0.812 (0.663-0.993) .043 1.201 (1.093-1.319) .001 
Hb level     
mmol/L 1.565 (0.883-2.774) .125 0.673 (0.479-0.946) .022 
Lactate dehydrogenase     
U/L 0.997 (0.993-1.000) .086 1.001 (0.999-1.003) .232 
Bilirubin     
μmol/L 1.001 (0.987-1.016) .856 1.003 (0.993-1.013) .601 
Reticulocytes     
0.996 (0.882-1.124) .944 1.019 (0.943-1.100) .640 

Significant P-values (P < 0.05) are shown in bold.

or Create an Account

Close Modal
Close Modal